Article Details
Retrieved on: 2022-05-14 11:31:52
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
MRNA has been the subject of a number of analyst reports. Barclays decreased their price target on Moderna from $404.00 to $210.00 in a research note ...
Article found on: www.etfdailynews.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here